ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

ACS Division Help Fund Some CIS Offices

September 13, 1985

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

M.D. Anderson Wins 11th SPORE Grant.

July 3, 2008

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

NCI Announces Designation Of Comprehensive Center

July 20, 1990